Akao M, Yasuda S, Kaikita K, Ako J, et al. Rivaroxaban Monotherapy versus Combination Therapy According to Patient Risk of Stroke and Bleeding in Atrial Fibrillation and Stable Coronary Disease: AFIRE trial sub-analysis. Am Heart J 2021 Feb 28. pii: S0002-8703(21)00063.
PMID: 33657403